Impact of Finerenone on Albuminuria in T1D, National Trends in Out-of-Pocket Cost for Glucose-Lowering Drugs, and more!
About this episode
This episode discusses the impact of Finerenone on albuminuria in Type 1 Diabetes and national trends in out-of-pocket costs for glucose-lowering drugs.
Welcome to the latest episode (August 2026) of DOC Updates , where every month Neil Skolnik, MD and John Russell, MD review the most important articles on diabetes, obesity, and cardiometabolic disease. This month on DOC Updates : Hirsh Elhence, Jennifer L. Dodge, Stephen Fuest, et al. National Prevalence of Clinical Obesity by BMI Class: A National Cross-Sectional Study . Ann Intern Med. [Epub 2 June 2026]. doi: 10.7326/ANNALS-25-05287 Eva Johnsen, et al. Achieving at Least 15% Weight Loss Within 2 Years of Type 2 Diabetes Diagnosis Is Associated With Lower Risks of Macrovascular and Microvascular Complications: A U.K. Cohort Study . Diabetes Care 20 July 2026; 49 (8): 1480–1489. doi.org/10.2337/dc26-0937 Carel W. le Roux, et al. Survodutide Once Weekly for the Treatment of Adults with Obesity . The New England Journal of Medicine June 2026 DOI: 10.1056/NEJMoa2600751 Yu Wang, Shichao Tang, Xilin Zhou, Ping Zhang. National Trends in Out-of-Pocket Cost for Glucose-Lowering Drugs Among U.S. Adults With Diabetes, 2000–2022 . Diabetes Care 20 July 2026; 49 (8): 1414–1419. https://doi.org/10.2337/dc25-2040 Jelle M. Beernink, et al. Effect of Finerenone on Albuminuria in Type 1…
People in this episode
Hosts: Neil Skolnik, MD, John Russell, MD
Topics covered
- Finerenone
- Albuminuria
- Type 1 Diabetes
- Out-of-Pocket Costs
- Glucose-Lowering Drugs
- Obesity
- Diabetes Complications
Keywords
- Finerenone
- Albuminuria
- Type 1 Diabetes
- Out-of-Pocket Costs
- Glucose-Lowering Drugs
- Obesity
- Diabetes Complications
Mentioned in this episode
Organizations: American Diabetes Association
Books & works: Ann Intern Med, Diabetes Care, The New England Journal of Medicine
More episodes of DOC Updates
- Special Edition: Hypertension Part 2—Advanced Hypertension Management: Uncontrolled and Resistant Hypertension and the Importance of Aldosterone
- Special Edition: Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH)
- Special Edition: Evidence-Based Strategies for Weight Loss and Long-Term Weight Maintenance
- Special Edition: What's Next—The Role of Health Systems in Managing CKD Associated with T1D & T2D
- Katherine Tuttle on SGLT2s & CKD in T2D, Alexander Turchin on medications after Metformin, and High vs. Low CVD Risk, the ADA's statement on employment and diabetes, and more!
- Special Edition: Hypertension Part I—Overview and Management
Explore listener stats, chart rankings, contacts and more on the DOC Updates podcast page.